FDA Inspection
Speciality Pharma Manufacturing, LLCSpeciality Pharma Manufacturing, LLC – FDA Inspection, Apr 8, 2025
Record Details
This FDA Inspection record concerns Speciality Pharma Manufacturing, LLC, with an inspection on April 8, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 20fc53d3-8d26-470b-84d1-640ab2581ecb
Inspection Facts
- Inspection number
- 1266292
- FDA center
- Human Drugs
FDA Citations
7- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.84(d)(1)Component identity verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Speciality Pharma Manufacturing, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 6, 2025 | NAI | Compliance: Devices | |
| March 16, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Speciality Pharma Manufacturing, LLC
- FDA Inspection 1298558 - 2025-11-06
- FDA Inspection 1123069 - 2020-03-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.